About: Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $400.43 (+1.04%)
MDGL NASDAQ Madrigal Pharmaceuticals Inc
Loading watchlist status…
Madrigal Pharmaceuticals Inc share price
MDGL price activity
Last Price
$400.430
Change (24hr)
4.11 USD (1.04%)
Volume
2.31M
Volume (4w avg)
-
Open
$398.89
Day Range
$353.54 - $402.48
Previous Close
$396.32
Last Trade
04 Nov, 9:26 pm GMT+0
Delayed
04 Nov, 9:26 pm GMT+0
MDGL price performance
-6.95%
5D
-18.88%
1M
-31.24%
YTD
-15.85%
1Y
Delayed
04 Nov, 9:26 pm GMT+0
MDGL details
MDGL Market Signals